Synthesis and Selective Cytotoxic Activities on Rhabdomyosarcoma and Noncancerous Cells of Some Heterocyclic Chalcones
- PMID: 27005608
- PMCID: PMC6273843
- DOI: 10.3390/molecules21030329
Synthesis and Selective Cytotoxic Activities on Rhabdomyosarcoma and Noncancerous Cells of Some Heterocyclic Chalcones
Abstract
Chemically diverse heterocyclic chalcones were prepared and evaluated for cytotoxicity, aiming to push forward potency and selectivity. They were tested against rhabdomyosarcoma (RMS) and noncancerous cell line (LLC-PK1). The influence of heteroaryl patterns on rings A and B was studied. Heterocycle functionalities on both rings, such as phenothiazine, thiophene, furan and pyridine were evaluated. Notably, the introduction of three methoxy groups at positions 3, 4, 5 on ring B appears to be critical for cytotoxicity. The best compound, with potent and selective cytotoxicity (IC50 = 12.51 μM in comparison with the value 10.84 μM of paclitaxel), contains a phenothiazine moiety on ring A and a thiophene heterocycle on ring B. Most of the potential compounds only show weak cytoxicity on the noncancerous cell line LLC-PK1.
Keywords: LLC-PK1 cell; MTT; cytotoxicity; heterocyclic chalcones; rhabdomyosarcoma.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Anticancer Active Heterocyclic Chalcones: Recent Developments.Anticancer Agents Med Chem. 2021;21(5):558-566. doi: 10.2174/1871520620666200705215722. Anticancer Agents Med Chem. 2021. PMID: 32628595 Review.
-
Synthesis and biological evaluation of indolyl chalcones as antitumor agents.Bioorg Med Chem Lett. 2010 Jul 1;20(13):3916-9. doi: 10.1016/j.bmcl.2010.05.016. Epub 2010 May 13. Bioorg Med Chem Lett. 2010. PMID: 20627724
-
Synthesis and structure-activity relationship studies of furan-ring fused chalcones as antiproliferative agents.Anticancer Res. 2015 Feb;35(2):811-7. Anticancer Res. 2015. PMID: 25667461
-
Synthesis of Novel Heterocyclic Compounds Incorporate 4,5,6,7-Tetrahydrobenzo[b]thiophene Together with Their Cytotoxic Evaluations.Chem Pharm Bull (Tokyo). 2017;65(5):469-477. doi: 10.1248/cpb.c16-00925. Chem Pharm Bull (Tokyo). 2017. PMID: 28458368
-
Advances in chalcones with anticancer activities.Recent Pat Anticancer Drug Discov. 2015;10(1):97-115. doi: 10.2174/1574892809666140819153902. Recent Pat Anticancer Drug Discov. 2015. PMID: 25138130 Review.
Cited by
-
Heterocyclization of polarized system: synthesis, antioxidant and anti-inflammatory 4-(pyridin-3-yl)-6-(thiophen-2-yl) pyrimidine-2-thiol derivatives.Chem Cent J. 2018 Jun 8;12(1):68. doi: 10.1186/s13065-018-0437-y. Chem Cent J. 2018. PMID: 29881977 Free PMC article.
-
Chalcone Derivatives as Potential Inhibitors of P-Glycoprotein and NorA: An In Silico and In Vitro Study.Biomed Res Int. 2022 Mar 26;2022:9982453. doi: 10.1155/2022/9982453. eCollection 2022. Biomed Res Int. 2022. PMID: 35378788 Free PMC article.
-
Synthesis of Novel Chalcone-Based Phenothiazine Derivatives as Antioxidant and Anticancer Agents.Molecules. 2020 Oct 6;25(19):4566. doi: 10.3390/molecules25194566. Molecules. 2020. PMID: 33036301 Free PMC article.
References
-
- Willam H.M., Sheri L.S. Soft tissue sarcomas of childhood. Cancer Treat. Rev. 2004;30:269–280. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources